ATE240335T1 - Azaheterocyclylmethyl-derivate von 2,3,8,9- tetrahydro-7h-1,4-dioxino(2,3-e)indol-8-on - Google Patents

Azaheterocyclylmethyl-derivate von 2,3,8,9- tetrahydro-7h-1,4-dioxino(2,3-e)indol-8-on

Info

Publication number
ATE240335T1
ATE240335T1 AT97910866T AT97910866T ATE240335T1 AT E240335 T1 ATE240335 T1 AT E240335T1 AT 97910866 T AT97910866 T AT 97910866T AT 97910866 T AT97910866 T AT 97910866T AT E240335 T1 ATE240335 T1 AT E240335T1
Authority
AT
Austria
Prior art keywords
optionally substituted
defined above
hydrogen
phenyl
benzoisothiazolyl
Prior art date
Application number
AT97910866T
Other languages
English (en)
Inventor
Gary Paul Stack
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Application granted granted Critical
Publication of ATE240335T1 publication Critical patent/ATE240335T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT97910866T 1996-10-15 1997-10-10 Azaheterocyclylmethyl-derivate von 2,3,8,9- tetrahydro-7h-1,4-dioxino(2,3-e)indol-8-on ATE240335T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73280796A 1996-10-15 1996-10-15
PCT/US1997/018275 WO1998016530A1 (en) 1996-10-15 1997-10-10 AZAHETEROCYCLYMETHYL DERIVATIVES OF 2,3,8,9-TETRAHYDRO-7H-1,4-DIOXINO[2,3-e]INDOL-8-ONE

Publications (1)

Publication Number Publication Date
ATE240335T1 true ATE240335T1 (de) 2003-05-15

Family

ID=24945030

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97910866T ATE240335T1 (de) 1996-10-15 1997-10-10 Azaheterocyclylmethyl-derivate von 2,3,8,9- tetrahydro-7h-1,4-dioxino(2,3-e)indol-8-on

Country Status (10)

Country Link
EP (1) EP0932609B1 (de)
JP (1) JP2001502327A (de)
AT (1) ATE240335T1 (de)
AU (1) AU4813897A (de)
CA (1) CA2268195C (de)
DE (1) DE69722020T2 (de)
DK (1) DK0932609T3 (de)
ES (1) ES2196312T3 (de)
PT (1) PT932609E (de)
WO (1) WO1998016530A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9627005D0 (en) * 1996-12-27 1997-02-12 Knoll Ag Therapeutic agents
WO2002088129A1 (en) * 2001-04-26 2002-11-07 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinazoline
US6800641B2 (en) 2001-04-26 2004-10-05 Wyeth Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-2,3-diaza-cyclopenta[a]naphthalene
ATE279415T1 (de) 2001-04-26 2004-10-15 Wyeth Corp Antidepressiv wirksame azaheterocyclymethyl- derivative von oxaheterocycyl-anellierten (1,4)- benzodioxanen
US6706736B2 (en) 2001-04-26 2004-03-16 Wyeth Antidepressant azaheterocyclylmethyl derivatives of oxaheterocycle-fused-[1,4]-benzodioxans
US6927226B2 (en) 2001-04-26 2005-08-09 Wyeth Antidepressant azaheterocyclymethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diazacyclopenta[a]naphthalene
DE60206048T2 (de) * 2001-04-26 2006-07-13 Wyeth Antidepressive (sssri) azaheterocyclylmethylderivate von 7,8-dihydro-3h-6,9-dioxa-1,3-diazacyclopenta [a] naphthalin
US6861427B2 (en) * 2001-04-26 2005-03-01 Wyeth Azabicyclylmethyl derivatives of 2,3-dihydro-1,4-dioxino[2,3-f]quinoline as 5-HT1A antagonists
US6617334B2 (en) 2001-04-30 2003-09-09 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
US6525075B2 (en) 2001-04-30 2003-02-25 Wyeth Antidepressant azaheterocyclylmethyl derivatives of 7,8-dihydro-1,6,9-trioxa-3-aza-cyclopenta[a]naphthalene
US7504395B2 (en) 2001-07-20 2009-03-17 Psychogenics, Inc. Treatment for attention-deficit hyperactivity disorder
US6939877B2 (en) * 2002-09-12 2005-09-06 Wyeth Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
US7153849B2 (en) 2002-09-12 2006-12-26 Wyeth Antidepressant arylpiperazine derivatives of hetrocycle-fused benzodioxans

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991013872A1 (en) * 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
DE4140540A1 (de) * 1991-12-09 1993-06-17 Bayer Ag Neue azaheterocyclylmethyl-chromane
AR004523A1 (es) * 1995-11-06 1998-12-16 American Home Prod 2-(AMINOMETIL)-3,4,7,9-TETRAHIDRO-2H-PIRANO-[2,3e] INDOL-8-ONAS Y COMPOSICIONES FARMACEUTICAS QUE LAS COMPRENDEN

Also Published As

Publication number Publication date
ES2196312T3 (es) 2003-12-16
EP0932609A1 (de) 1999-08-04
DK0932609T3 (da) 2003-09-01
WO1998016530A1 (en) 1998-04-23
AU4813897A (en) 1998-05-11
DE69722020T2 (de) 2004-01-22
DE69722020D1 (de) 2003-06-18
PT932609E (pt) 2003-09-30
JP2001502327A (ja) 2001-02-20
CA2268195C (en) 2006-08-29
CA2268195A1 (en) 1998-04-23
EP0932609B1 (de) 2003-05-14

Similar Documents

Publication Publication Date Title
ATE240335T1 (de) Azaheterocyclylmethyl-derivate von 2,3,8,9- tetrahydro-7h-1,4-dioxino(2,3-e)indol-8-on
TW222584B (de)
SI1312359T1 (sl) Uporaba 1,3-propandiolnih spojin
TW375615B (en) Galanthamine derivatives and their use as medicaments
MX9803455A (es) Derivados de indolalquilo de benzodioxanmetilamina como ligandos del receptor 5-ht1a.
HK1012341A1 (en) Pyrrolocarbazole
WO1994019343A3 (en) Novel use as anti-inflammatory agents for bis-heterocyclic compounds and pharmaceutical compositions thereof
NZ333798A (en) Arylcycloalkane carboxylic esters, their use for the treatment of urinary incontinence or irritable bowel syndrome, and method of manufacture.
CA2268399A1 (en) Anti-neurogenic inflammatory compounds and compositions and methods of use thereof
AU4200089A (en) Substituted beta-diketones
GB2151624B (en) Imidazo1 2-cpyrimidine
IL132799A0 (en) 17Beta-allyloxy(thio)alkyl-androstane derivatives for the modulation of meiosis
MY108849A (en) Novel compound
YU140491A (sh) 6-supstituisani-tetrahidrobenz(c,d) indoli
CA2144974A1 (en) Camphidine derivative, production thereof, and use thereof

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0932609

Country of ref document: EP

REN Ceased due to non-payment of the annual fee